Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 46% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| muscle | 100% | 30356.99 | 803 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 9407.29 | 855 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 76% | 832.41 | 196 / 258 | 16% | 1.29 | 36 / 230 |
| pancreas | 0% | 1.42 | 1 / 328 | 79% | 11.92 | 141 / 178 |
| thymus | 1% | 9.49 | 7 / 653 | 72% | 4.90 | 436 / 605 |
| kidney | 3% | 11.98 | 3 / 89 | 46% | 4.42 | 417 / 901 |
| stomach | 0% | 0 | 0 / 359 | 50% | 3.87 | 142 / 286 |
| intestine | 0% | 2.16 | 4 / 966 | 46% | 3.61 | 240 / 527 |
| uterus | 10% | 53.59 | 17 / 170 | 33% | 6.64 | 151 / 459 |
| brain | 17% | 117.19 | 450 / 2642 | 19% | 0.41 | 133 / 705 |
| esophagus | 1% | 12.29 | 15 / 1445 | 34% | 2.75 | 63 / 183 |
| eye | 0% | 0 | 0 / 0 | 34% | 1.11 | 27 / 80 |
| lung | 0% | 9.43 | 2 / 578 | 33% | 2.43 | 381 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 2.40 | 13 / 45 |
| ovary | 3% | 15.99 | 5 / 180 | 24% | 0.86 | 105 / 430 |
| prostate | 11% | 152.89 | 26 / 245 | 16% | 1.25 | 82 / 502 |
| bladder | 0% | 0 | 0 / 21 | 25% | 1.58 | 124 / 504 |
| liver | 0% | 0 | 0 / 226 | 23% | 1.80 | 94 / 406 |
| breast | 1% | 13.90 | 6 / 459 | 8% | 0.28 | 95 / 1118 |
| skin | 0% | 30.17 | 5 / 1809 | 9% | 0.48 | 41 / 472 |
| blood vessel | 5% | 66.51 | 71 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 3% | 20.09 | 8 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 2% | 22.63 | 15 / 929 | 0% | 0 | 0 / 0 |
| adipose | 1% | 5.58 | 12 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007017 | Biological process | microtubule-based process |
| GO_0007165 | Biological process | signal transduction |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0030154 | Biological process | cell differentiation |
| GO_0007026 | Biological process | negative regulation of microtubule depolymerization |
| GO_0030018 | Cellular component | Z disc |
| GO_0005875 | Cellular component | microtubule associated complex |
| GO_0005874 | Cellular component | microtubule |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008017 | Molecular function | microtubule binding |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | TRIM54 |
| Protein name | Tripartite motif-containing protein 54 (Muscle-specific RING finger protein) (MuRF) (Muscle-specific RING finger protein 3) (MuRF-3) (MuRF3) (RING finger protein 30) |
| Synonyms | MURF MURF3 RNF30 |
| Description | FUNCTION: May bind and stabilize microtubules during myotubes formation. . |
| Accessions | ENST00000296098.4 [Q9BYV2-2] Q9BYV2 ENST00000380075.7 [Q9BYV2-1] |